WATCHMAN FLX™ CT Study

NCT05324371 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Interventions

DEVICE: Watchman FLX Device

Sponsor

Boston Scientific Corporation